General Information of Drug Therapeutic Target (DTT) (ID: TTP6W8J)

DTT Name Fructosamine-3-kinase (FN3K)
Synonyms Fructosamine 3 kinase; FN3K; F3K
Gene Name FN3K
DTT Type
Literature-reported target
[1]
BioChemical Class
Kinase
UniProt ID
FN3K_HUMAN
TTD ID
T92296
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
EC Number
EC 2.7.1.-
Sequence
MEQLLRAELRTATLRAFGGPGAGCISEGRAYDTDAGPVFVKVNRRTQARQMFEGEVASLE
ALRSTGLVRVPRPMKVIDLPGGGAAFVMEHLKMKSLSSQASKLGEQMADLHLYNQKLREK
LKEEENTVGRRGEGAEPQYVDKFGFHTVTCCGFIPQVNEWQDDWPTFFARHRLQAQLDLI
EKDYADREARELWSRLQVKIPDLFCGLEIVPALLHGDLWSGNVAEDDVGPIIYDPASFYG
HSEFELAIALMFGGFPRSFFTAYHRKIPKAPGFDQRLLLYQLFNYLNHWNHFGREYRSPS
LGTMRRLLK
Function
May initiate a process leading to the deglycation of fructoselysine and of glycated proteins. May play a role in the phosphorylation of 1-deoxy-1-morpholinofructose (DMF), fructoselysine, fructoseglycine, fructose and glycated lysozyme.
Reactome Pathway
Gamma carboxylation, hypusine formation and arylsulfatase activation (R-HSA-163841 )
BioCyc Pathway
MetaCyc:ENSG00000167363-MON

References

1 Evidence That Differences in Fructosamine-3-Kinase Activity May Be Associated With the Glycation Gap in Human Diabetes. Diabetes. 2018 Jan;67(1):131-136.